Cancers 2010, 2(2), 364-375; doi:10.3390/cancers2020364
Review

Cerebral Metastases from Malignant Melanoma: Current Treatment Strategies, Advances in Novel Therapeutics and Future Directions

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
* Author to whom correspondence should be addressed.
Received: 11 March 2010; in revised form: 25 March 2010 / Accepted: 1 April 2010 / Published: 6 April 2010
PDF Full-text Download PDF Full-Text [241 KB, uploaded 6 April 2010 13:35 CEST]
Abstract: Of all primary cancers in humans, melanoma has the highest propensity to metastasize to the brain. The prognosis of patients with this disease is extremely poor. Due to its radioresistance and poor response to existing chemotherapeutic regimes, no treatment options other than surgical extirpation, when feasible, have been shown to be effective. An understanding of the underlying tumor biology therefore remains the cornerstone of offering new hope in the treatment. In this review, we comment on the current treatment strategies for melanoma brain metastases and summarize some recent experimental findings from our laboratory with potential for the development of target specific antitumor therapies.
Keywords: cerebral metastasis; melanoma; surgery; radiotherapy; drug therapy; STAT3 transcription factor

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Siu, T.L.; Huang, S. Cerebral Metastases from Malignant Melanoma: Current Treatment Strategies, Advances in Novel Therapeutics and Future Directions. Cancers 2010, 2, 364-375.

AMA Style

Siu TL, Huang S. Cerebral Metastases from Malignant Melanoma: Current Treatment Strategies, Advances in Novel Therapeutics and Future Directions. Cancers. 2010; 2(2):364-375.

Chicago/Turabian Style

Siu, Timothy L.; Huang, Suyun. 2010. "Cerebral Metastases from Malignant Melanoma: Current Treatment Strategies, Advances in Novel Therapeutics and Future Directions." Cancers 2, no. 2: 364-375.

Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert